Furthermore, Liu et al. reported that TAK1 deletion is associated with high-grade prostate cancer in humans [50]; Wu et al. subsequently found that TAK1 knockdown in prostate stem cells engrafted into mice displayed features of prostatic intraepithelial neoplasia and invasive carcinoma [51]. The gene discussed is MAP3K7; the disease is prostate intraepithelial neoplasia.